• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奎尼丁和奎宁的立体选择性肾小管分泌

Stereoselective renal tubular secretion of quinidine and quinine.

作者信息

Notterman D A, Drayer D E, Metakis L, Reidenberg M M

出版信息

Clin Pharmacol Ther. 1986 Nov;40(5):511-7. doi: 10.1038/clpt.1986.216.

DOI:10.1038/clpt.1986.216
PMID:3769382
Abstract

Quinidine and quinine are stereoisomers. When given sequentially or simultaneously, the renal clearance of values of quinidine and quinine were measured in seven healthy volunteers and when given simultaneously, to an additional five elderly men. Analytic specificity was provided by an HPLC drug assay. Protein binding was measured by equilibrium dialysis. The quinidine clearance exceeded the quinine clearance in every individual. The mean (+/- SD) ratio of these clearances was 4.2 +/- 1.4 when the drugs were given together and 4.4 +/- 2.3 when they were given separately in the younger subjects and 3.4 +/- 0.5 when given simultaneously to the elderly. Calculating clearance of drug in serum water (unbound drug clearance) revealed a quinidine clearance of 6.1 +/- 2.3 times that of creatinine measured simultaneously, and for quinine it was 1.5 +/- 0.6 times that of creatinine. We conclude that there is stereoselective net renal tubular secretion of quinidine over quinine indicating stereoselectivity of this renal tubular transport process.

摘要

奎尼丁和奎宁是立体异构体。在七名健康志愿者中依次或同时给予这两种药物后,测量了奎尼丁和奎宁的肾清除率,并在另外五名老年男性中同时给予这两种药物。通过高效液相色谱法药物分析提供分析特异性。通过平衡透析测量蛋白质结合。在每个个体中,奎尼丁的清除率均超过奎宁的清除率。在年轻受试者中,当两种药物一起给予时,这些清除率的平均(±标准差)比值为4.2±1.4,分开给予时为4.4±2.3,在老年受试者中同时给予时为3.4±0.5。计算血清水中药物的清除率(未结合药物清除率)显示,奎尼丁的清除率是同时测量的肌酐清除率的6.1±2.3倍,而奎宁的清除率是肌酐清除率的1.5±0.6倍。我们得出结论,与奎宁相比,存在对奎尼丁的立体选择性净肾小管分泌,表明该肾小管转运过程具有立体选择性。

相似文献

1
Stereoselective renal tubular secretion of quinidine and quinine.奎尼丁和奎宁的立体选择性肾小管分泌
Clin Pharmacol Ther. 1986 Nov;40(5):511-7. doi: 10.1038/clpt.1986.216.
2
Interactions in the renal and biliary elimination of digoxin: stereoselective difference between quinine and quinidine.地高辛经肾和胆汁消除过程中的相互作用:奎宁和奎尼丁之间的立体选择性差异。
Clin Pharmacol Ther. 1990 Jan;47(1):20-6. doi: 10.1038/clpt.1990.3.
3
Gender-associated differences in rat renal tubular amantadine transport and absence of stereoselective transport inhibition by quinine and quinidine in distal tubules.大鼠肾小管中金刚烷胺转运的性别相关差异以及远端小管中奎宁和奎尼丁不存在立体选择性转运抑制作用
J Pharmacol Exp Ther. 1993 Dec;267(3):1440-4.
4
Disposition of the diastereoisomers quinine and quinidine in the ovine fetus.非对映异构体奎宁和奎尼丁在绵羊胎儿体内的处置情况。
J Pharm Sci. 1991 May;80(5):445-8. doi: 10.1002/jps.2600800510.
5
Stereoselective inhibition of amantadine accumulation by quinine and quinidine in rat renal proximal tubules and cortical slices.奎宁和奎尼丁对大鼠肾近端小管和皮质切片中金刚烷胺蓄积的立体选择性抑制作用。
J Pharmacol Exp Ther. 1990 Oct;255(1):271-5.
6
Comparison of pharmacokinetic parameters of intravenous quinidine and quinine in dogs.
J Cardiovasc Pharmacol. 1982 Jan-Feb;4(1):107-10. doi: 10.1097/00005344-198201000-00017.
7
The stereoisomers quinine and quinidine exhibit a marked stereoselectivity in the inhibition of hepatobiliary transport of cardiac glycosides.立体异构体奎宁和奎尼丁在抑制强心苷的肝胆转运方面表现出显著的立体选择性。
J Hepatol. 1998 Feb;28(2):240-9. doi: 10.1016/0168-8278(88)80011-4.
8
Comparative disposition kinetics of two diastereomeric pairs of cinchona alkaloids in the dog.犬体内两种非对映体奎宁生物碱对的比较处置动力学
J Pharm Sci. 1984 Apr;73(4):452-6. doi: 10.1002/jps.2600730407.
9
Reduced quinidine clearance in elderly persons.
Am J Cardiol. 1978 Sep;42(3):481-5. doi: 10.1016/0002-9149(78)90944-x.
10
High affinity of quinidine for a stereoselective microsomal binding site as determined by a radioreceptor assay.通过放射受体分析法测定,奎尼丁对立体选择性微粒体结合位点具有高亲和力。
Experientia. 1984 Sep 15;40(9):973-4. doi: 10.1007/BF01946465.

引用本文的文献

1
Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models.人有机阳离子转运体1介导的药物和内源性化合物转运:单转染和双转染细胞模型研究
Front Pharmacol. 2021 Apr 22;12:662535. doi: 10.3389/fphar.2021.662535. eCollection 2021.
2
Stereoselective inhibition of serotonin transporters by antimalarial compounds.抗疟化合物对5-羟色胺转运体的立体选择性抑制作用。
Neurochem Int. 2014 Jul;73:98-106. doi: 10.1016/j.neuint.2013.10.009. Epub 2013 Oct 23.
3
Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.
疟原虫 CRT 蛋白中的突变决定了抗疟金鸡纳生物碱的立体特异性活性。
Antimicrob Agents Chemother. 2012 Oct;56(10):5356-64. doi: 10.1128/AAC.05667-11. Epub 2012 Aug 6.
4
Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.手性抗疟药物的药效学和药代动力学中的立体选择性。
Clin Pharmacokinet. 2003;42(15):1359-82. doi: 10.2165/00003088-200342150-00004.
5
Measurement of renal function during drug development.药物研发过程中的肾功能测量。
Br J Clin Pharmacol. 2002 Jul;54(1):87-95. doi: 10.1046/j.1365-2125.2002.01625.x.
6
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.双氯芬酸、双硫仑、伊曲康唑、葡萄柚汁及红霉素对奎尼丁药代动力学的影响。
Br J Clin Pharmacol. 1999 Dec;48(6):829-38. doi: 10.1046/j.1365-2125.1999.00099.x.
7
Pharmacological importance of stereochemical resolution of enantiomeric drugs.对映体药物立体化学拆分的药理学重要性。
Drug Saf. 1997 Sep;17(3):149-65. doi: 10.2165/00002018-199717030-00002.
8
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.奎宁、氯喹和阿莫地喹的药代动力学。临床意义。
Clin Pharmacokinet. 1996 Apr;30(4):263-99. doi: 10.2165/00003088-199630040-00002.
9
Pharmacokinetics of quinine in patients with chronic renal failure.慢性肾功能衰竭患者中奎宁的药代动力学。
Eur J Clin Pharmacol. 1996;49(6):497-501. doi: 10.1007/BF00195937.
10
Stereoselective interactions of organic cations with the organic cation transporter in OK cells.有机阳离子与OK细胞中有机阳离子转运体的立体选择性相互作用。
Pharm Res. 1993 Aug;10(8):1169-73. doi: 10.1023/a:1018968218573.